Lannett Company plans to co-develop generic insulin for the U.S. market with its strategic partner in China, YiChang HEC ChangJiang Pharmaceutical, an HEC Group company. The product is currently in late stage development
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Don’t see a project related to the strategic initiative you care about?